Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.

Zhu H, Fang J, Zhang J, Zhao Z, Liu L, Wang J, Xi Q, Gu M.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):857-62. doi: 10.1016/j.bbrc.2014.06.073. Epub 2014 Jun 24.

PMID:
24971532
2.

MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.

Liu L, Wang J, Li X, Ma J, Shi C, Zhu H, Xi Q, Zhang J, Zhao X, Gu M.

Biochem Biophys Res Commun. 2015 Feb 20;457(4):621-6. doi: 10.1016/j.bbrc.2015.01.037. Epub 2015 Jan 17.

PMID:
25603050
3.

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.

Wen Q, Zhao J, Bai L, Wang T, Zhang H, Ma Q.

Oncol Rep. 2015 Oct;34(4):2202-10. doi: 10.3892/or.2015.4165. Epub 2015 Jul 31.

PMID:
26239517
4.

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Ma Y, Qin H, Cui Y.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):958-63. doi: 10.1016/j.bbrc.2013.11.010. Epub 2013 Nov 9.

PMID:
24220341
5.

miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.

Wei C, Song H, Sun X, Li D, Song J, Hua K, Fang L.

Oncol Rep. 2015 Jul;34(1):211-20. doi: 10.3892/or.2015.3971. Epub 2015 May 11.

PMID:
26063221
6.

MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.

Lima CR, Geraldo MV, Fuziwara CS, Kimura ET, Santos MF.

BMC Cancer. 2016 Feb 16;16:108. doi: 10.1186/s12885-016-2146-z.

7.

Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.

Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1305-13. doi: 10.1210/jc.2012-3602. Epub 2013 Jun 24.

PMID:
23796566
8.

miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.

Ma S, Jia W, Ni S.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):181-186. doi: 10.1016/j.bbrc.2018.02.051. Epub 2018 Feb 8.

PMID:
29427661
9.

MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.

Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q, Guan H, Li Y, Xiao H.

Thyroid. 2016 Dec;26(12):1733-1743. Epub 2016 Nov 2.

PMID:
27717302
10.

MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.

Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z.

Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.

11.

miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Li R, Liu J, Li Q, Chen G, Yu X.

Tumour Biol. 2016 Mar;37(3):3987-96. doi: 10.1007/s13277-015-4165-9. Epub 2015 Oct 19.

PMID:
26482618
12.

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.

Cancer Sci. 2008 Feb;99(2):280-6. doi: 10.1111/j.1349-7006.2007.00666.x. Epub 2008 Jan 14.

13.

MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Qiu W, Yang Z, Fan Y, Zheng Q.

Oncotarget. 2016 Jun 28;7(26):39907-39915. doi: 10.18632/oncotarget.9530.

14.

MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Song HM, Luo Y, Li DF, Wei CK, Hua KY, Song JL, Xu H, Maskey N, Fang L.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9889-900. eCollection 2015.

15.

MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.

Dong S, Jin M, Li Y, Ren P, Liu J.

Oncol Rep. 2016 Apr;35(4):2151-8. doi: 10.3892/or.2016.4604. Epub 2016 Feb 1.

PMID:
26847706
16.

Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.

Wang XZ, Hang YK, Liu JB, Hou YQ, Wang N, Wang MJ.

J Pharmacol Sci. 2016 Feb;130(2):78-84. doi: 10.1016/j.jphs.2015.12.001. Epub 2015 Dec 12.

17.

MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.

Wang Z, Zhang H, Zhang P, Dong W, He L.

Tumour Biol. 2016 Jun;37(6):7633-44. doi: 10.1007/s13277-015-4653-y. Epub 2015 Dec 19.

PMID:
26687649
18.

Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.

Meng W, Wang PS, Liu J, Xue S, Wang GM, Meng XY, Chen G.

Oncol Rep. 2014 Dec;32(6):2411-20. doi: 10.3892/or.2014.3483. Epub 2014 Sep 16.

PMID:
25231838
19.

miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.

Ma X, Wei J, Zhang L, Deng D, Liu L, Mei X, He X, Tian J.

Biomed Pharmacother. 2016 May;80:220-226. doi: 10.1016/j.biopha.2016.03.020. Epub 2016 Mar 28.

PMID:
27133060
20.

IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.

Chou CK, Chi SY, Huang CH, Chou FF, Huang CC, Liu RT, Kang HY.

J Clin Endocrinol Metab. 2016 Nov;101(11):4357-4366. Epub 2016 Aug 17.

PMID:
27533309

Supplemental Content

Support Center